頭頸部がん治療薬の世界市場レポート 2024

頭頸部がん治療薬の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には10.4%の年間複合成長率（CAGR）で25億7,000万米ドルに成長すると予想されます。予測される成長は、免疫療法の進歩、精密医療戦略の採用、早期診断の取り組みによる意識の向上、そして世界の高齢化人口の拡大によるものと考えられます。予測期間の主な動向には、標的療法の利用拡大、低侵襲外科法の統合、緩和ケアの組み込み、新しいバイオマーカーの探索、患者中心のケアモデルの導入などが含まれます。

頭頸部がんの罹患率の上昇は、頭頸部がん治療薬市場の成長を促進すると予想されます。この病状には、頭頸部領域の組織における細胞の制御されない増殖が含まれており、がん細胞の変異や異常に対処するための診断および治療の選択肢の改善が必要です。 2023年、Cancer Research UKの予測では、2023年から2025年の間に英国における頭頸部がんの発生率が3%増加することが示されています。さらに、頭頸部がんによる死亡は同期間に12%増加すると予想されています。効果的な治療介入の必要性が高まっていることを強調しています。

タバコとアルコールの高い消費量は、頭頸部がん治療薬市場の拡大に寄与すると予想されます。タバコ製品やアルコール飲料を習慣的に使用すると、口、喉、喉頭、その他の領域の内壁が発がん性物質にさらされ、頭頸部がんのリスクが高まります。特に、2023年8月に米国家庭医学会は、電子タバコの販売本数が大幅に増加し、2020年1月から2022年12月までに46%以上増加したと報告しました。この増加は、米国の成人の間での電子タバコの使用の増加と連動しています。 2020年の3.7%から2022年には6%に上昇し、頭頸部がんの有病率に対する大量のタバコ消費の影響が強調され、それによって治療ソリューションの需要が高まっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の頭頸部がん治療薬市場促進要因と制約要因
  • 市場の促進要因
  • 市場の抑制要因
• 世界の頭頸部がん治療薬市場規模実績と成長、2018年～2023年
• 世界の頭頸部がん治療薬市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の頭頸部がん治療薬市場、タイプ別セグメンテーション、実績および予測、2018～2023年、2023～2028年、2033年
• プログラム細胞死（PD）阻害剤
• 微小管阻害剤
• 上皮成長因子受容体（EGFR）阻害剤
• 世界の頭頸部がん治療薬市場、投与経路別セグメンテーション、実績および予測、2018～2023年、2023～2028年、2033年
• 注射
• 経口
• 世界の頭頸部がん治療薬市場、流通チャネル別セグメンテーション、実績および予測、2018～2023年、2023～2028年、2033年
• 小売薬局・専門薬局
• 病院薬局
• オンライン薬局
• 世界の頭頸部がん治療薬市場、用途別セグメンテーション、実績および予測、2018～2023年、2023～2028年、2033年
• 手術
• 放射線治療
• 化学療法
• 免疫療法
• その他の用途

第7章 地域および国の分析

• 世界の頭頸部がん治療薬市場、地域別、実績および予測、2018～2023年、2023～2028年、2033年
• 世界の頭頸部がん治療薬市場、国別、実績および予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 頭頸部がん治療薬市場の競合情勢
• 頭頸部がん治療薬市場の企業プロファイル
  • Pfizer Inc.
  • F Hoffmann-La Roche Ltd.
  • Merck &Co. Inc.
  • AbbVie Inc.
  • Bayer AG

第31章 その他の大手および革新的な企業

• Novartis AG
• Sanofi Aventis LLC
• Bristol-Myers-Squibb Company
• AstraZeneca PLC
• GlaxoSmithKline plc.
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Gilead Sciences Inc.
• Amgen Inc.
• Boehringer Ingelheim International GmbH
• Teva Pharmaceutical Industries Ltd.
• Astellas Pharma Inc.
• Daiichi Sankyo Company Limited
• Eisai Co. Ltd.
• Sun Pharmaceutical Industries Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Head and neck cancer therapeutics encompass a range of treatments designed to address and manage cancers affecting these areas. Precision therapies such as intensity-modulated proton therapy are beneficial in this domain. This includes an array of treatments such as surgery, radiation therapy, chemotherapy, specialized medications, and immunotherapy to combat these specific cancers.

The primary types of head and neck cancer therapeutics are programmed cell death (PD) inhibitors, microtubule inhibitors, and epidermal growth factor receptor (EGFR) inhibitors. PD inhibitors, such as programmed cell death protein 1 (PD-1) inhibitors, function by obstructing interactions between PD-1 and its ligands, PD-L1 and PD-L2, present in certain cancer cells. These medications are administered through injectable or oral routes and are available through multiple distribution channels such as retail and specialty pharmacies, hospital pharmacies, and online pharmacies. They find application in surgery, radiation therapy, chemotherapy, immunotherapy, and other treatment modalities.

The head and neck cancer therapeutics research report is one of a series of new reports from The Business Research Company that provides head and neck cancer therapeutics market statistics, including the head and neck cancer therapeutics industry's global market size, regional shares, competitors with head and neck cancer therapeutics market share, detailed head and neck cancer therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the head and neck cancer therapeutics industry. This head and neck cancer therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The head and neck cancer therapeutics market size has grown rapidly in recent years. It will grow from $1.55 billion in 2023 to $1.73 billion in 2024 at a compound annual growth rate (CAGR) of 11.7%. The growth observed in previous periods can be attributed to increased sales in the tobacco and alcohol industries, rising cases of human papillomavirus (HPV) infections, environmental exposures, and advancements in treatment methods.

The head and neck cancer therapeutics market size is expected to see rapid growth in the next few years. It will grow to $2.57 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The projected growth can be credited to advancements in immunotherapy, the adoption of precision medicine strategies, increased awareness through early diagnosis initiatives, and the expanding aging population worldwide. Key trends in the forecast period encompass the growing utilization of targeted therapies, the integration of minimally invasive surgical methods, the incorporation of palliative care, exploration into new biomarkers, and the implementation of patient-centric care models.

The rising prevalence of head and neck cancer is anticipated to drive the growth of the head and neck cancer therapeutics market. This medical condition involves the uncontrolled growth of cells in the tissues of the head and neck region, necessitating improved diagnostic and treatment options to address mutations and abnormalities in cancer cells. In 2023, projections from Cancer Research UK indicate a 3% increase in the incidence of head and neck cancer in the UK between 2023 and 2025. Additionally, deaths attributed to head and neck cancers are expected to rise by 12% during the same period, underscoring the growing need for effective therapeutic interventions.

The consumption of tobacco and alcohol at high levels is expected to contribute to the expansion of the head and neck cancer therapeutics market. Habitual use of tobacco products and alcoholic beverages exposes the lining of the mouth, throat, larynx, and other areas to carcinogenic substances, leading to an increased risk of head and neck cancer. Notably, in August 2023, the American Academy of Family Physicians reported a significant surge in e-cigarette unit sales, rising by over 46% from January 2020 to December 2022. This increase, along with a rise in e-cigarette use among U.S. adults to 6% in 2022 from 3.7% in 2020, emphasizes the impact of high tobacco consumption on the prevalence of head and neck cancer, thereby driving the demand for therapeutic solutions.

Leading companies in the head and neck cancer therapeutics market are focused on introducing novel drug treatments to address the needs of patients with head and neck cancer. Drug treatment involves the use of pharmaceutical substances to manage or alleviate medical conditions, and in October 2023, Coherus BioSciences Inc., a U.S.-based biopharmaceutical company, achieved FDA approval for its latest drug, 'Loqtorzi' (toripalimab-tpzi). The approval allows for the use of the drug in combination with cisplatin and gemcitabine as the initial treatment for adults diagnosed with metastatic or recurrent, locally advanced nasopharyngeal carcinoma. The clinical trial demonstrated favorable results, with adverse reactions occurring in fewer than 20% of patients, whether used as a first-line option or as a single-agent therapy.

Major players in the head and neck cancer therapeutics market are also dedicated to developing innovative solutions, such as AI-enabled MR (Magnetic Resonance) imaging. This approach involves incorporating artificial intelligence (AI) technology into the MR process, optimizing various aspects from image acquisition to interpretation. In October 2022, Koninklijke Philips N.V., a Netherlands-based health technology company, received FDA approval for two advances in MR-only workflows such as (AI)-enabled MRCAT Head and Neck' and 'MacroMedics.' The (AI)-enabled MRCAT Head and Neck radiotherapy application facilitates the use of MR as the exclusive or primary imaging modality for planning radiotherapy, especially for soft tissue tumors located in the head and neck, as well as in the brain, pelvis, and prostate.

In March 2023, InvoX Pharma Ltd., a UK-based biopharmaceutical company, completed the acquisition of F-star Therapeutics Inc. for a sum of $161 million. This strategic move fortified InvoX Pharma's standing in the cancer therapeutics sector, expanding its portfolio and broadening its market reach. F-star Therapeutics Inc., based in the US, specializes in clinical-stage biopharmaceuticals, particularly focusing on head and neck cancer immunotherapy.

Major companies operating in the head and neck cancer therapeutics market report are Pfizer Inc., F Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi Aventis LLC, Bristol-Myers-Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Incyte Corporation, Ono Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd., Hikma Pharmaceuticals PLC, Clinigen Group plc., Ligand Pharmaceuticals, Acceleron Pharma Inc., Taiho Pharmaceutical Co. Ltd., Boston Biomedical Inc., AB Science SA.

North America was the largest region in the head and neck cancer therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the head and neck cancer therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the head and neck cancer therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The head and neck cancer therapeutics market consists of sales of bleomycin sulfate, cetuximab, docetaxel, and erbitux. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Head And Neck Cancer Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on head and neck cancer therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for head and neck cancer therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The head and neck cancer therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Programmed Cell Death (PD) Inhibitors; Microtubule Inhibitors; Epidermal Growth Factor Receptor (EGFR) Inhibitors
• 2) By Route Of Administration: Injectable; Oral
• 3) By Distribution Channel: Retail And Specialty Pharmacies; Hospital Pharmacies; Online Pharmacies
• 4) By Application: Surgery; Radiation Therapy; Chemotherapy; Immunotherapy; Other Applications
• Companies Mentioned: Pfizer Inc.; F Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Head And Neck Cancer Therapeutics Market Characteristics

3. Head And Neck Cancer Therapeutics Market Trends And Strategies

4. Head And Neck Cancer Therapeutics Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Head And Neck Cancer Therapeutics Market Size and Growth

• 5.1. Global Head And Neck Cancer Therapeutics Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Head And Neck Cancer Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Head And Neck Cancer Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Head And Neck Cancer Therapeutics Market Segmentation

• 6.1. Global Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Programmed Cell Death (PD) Inhibitors
• Microtubule Inhibitors
• Epidermal Growth Factor Receptor (EGFR) Inhibitors
• 6.2. Global Head And Neck Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Injectable
• Oral
• 6.3. Global Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Retail And Specialty Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• 6.4. Global Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Surgery
• Radiation Therapy
• Chemotherapy
• Immunotherapy
• Other Applications

7. Head And Neck Cancer Therapeutics Market Regional And Country Analysis

• 7.1. Global Head And Neck Cancer Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Head And Neck Cancer Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Head And Neck Cancer Therapeutics Market

• 8.1. Asia-Pacific Head And Neck Cancer Therapeutics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Head And Neck Cancer Therapeutics Market

• 9.1. China Head And Neck Cancer Therapeutics Market Overview
• 9.2. China Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Head And Neck Cancer Therapeutics Market

• 10.1. India Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Head And Neck Cancer Therapeutics Market

• 11.1. Japan Head And Neck Cancer Therapeutics Market Overview
• 11.2. Japan Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Head And Neck Cancer Therapeutics Market

• 12.1. Australia Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Head And Neck Cancer Therapeutics Market

• 13.1. Indonesia Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Head And Neck Cancer Therapeutics Market

• 14.1. South Korea Head And Neck Cancer Therapeutics Market Overview
• 14.2. South Korea Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Head And Neck Cancer Therapeutics Market

• 15.1. Western Europe Head And Neck Cancer Therapeutics Market Overview
• 15.2. Western Europe Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Head And Neck Cancer Therapeutics Market

• 16.1. UK Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Head And Neck Cancer Therapeutics Market

• 17.1. Germany Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Head And Neck Cancer Therapeutics Market

• 18.1. France Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Head And Neck Cancer Therapeutics Market

• 19.1. Italy Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Head And Neck Cancer Therapeutics Market

• 20.1. Spain Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Head And Neck Cancer Therapeutics Market

• 21.1. Eastern Europe Head And Neck Cancer Therapeutics Market Overview
• 21.2. Eastern Europe Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Head And Neck Cancer Therapeutics Market

• 22.1. Russia Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Head And Neck Cancer Therapeutics Market

• 23.1. North America Head And Neck Cancer Therapeutics Market Overview
• 23.2. North America Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Head And Neck Cancer Therapeutics Market

• 24.1. USA Head And Neck Cancer Therapeutics Market Overview
• 24.2. USA Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Head And Neck Cancer Therapeutics Market

• 25.1. Canada Head And Neck Cancer Therapeutics Market Overview
• 25.2. Canada Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Head And Neck Cancer Therapeutics Market

• 26.1. South America Head And Neck Cancer Therapeutics Market Overview
• 26.2. South America Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Head And Neck Cancer Therapeutics Market

• 27.1. Brazil Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Head And Neck Cancer Therapeutics Market

• 28.1. Middle East Head And Neck Cancer Therapeutics Market Overview
• 28.2. Middle East Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Head And Neck Cancer Therapeutics Market

• 29.1. Africa Head And Neck Cancer Therapeutics Market Overview
• 29.2. Africa Head And Neck Cancer Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Head And Neck Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Head And Neck Cancer Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Head And Neck Cancer Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. Head And Neck Cancer Therapeutics Market Competitive Landscape
• 30.2. Head And Neck Cancer Therapeutics Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. F Hoffmann-La Roche Ltd.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Merck & Co. Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. AbbVie Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Bayer AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Head And Neck Cancer Therapeutics Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Sanofi Aventis LLC
• 31.3. Bristol-Myers-Squibb Company
• 31.4. AstraZeneca PLC
• 31.5. GlaxoSmithKline plc.
• 31.6. Takeda Pharmaceutical Company Limited
• 31.7. Eli Lilly and Company
• 31.8. Gilead Sciences Inc.
• 31.9. Amgen Inc.
• 31.10. Boehringer Ingelheim International GmbH
• 31.11. Teva Pharmaceutical Industries Ltd.
• 31.12. Astellas Pharma Inc.
• 31.13. Daiichi Sankyo Company Limited
• 31.14. Eisai Co. Ltd.
• 31.15. Sun Pharmaceutical Industries Ltd.

32. Global Head And Neck Cancer Therapeutics Market Competitive Benchmarking

33. Global Head And Neck Cancer Therapeutics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Head And Neck Cancer Therapeutics Market

35. Head And Neck Cancer Therapeutics Market Future Outlook and Potential Analysis

• 35.1 Head And Neck Cancer Therapeutics Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Head And Neck Cancer Therapeutics Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Head And Neck Cancer Therapeutics Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer